In this interview, entitled ‘Diab8: The randomized clinical trial comparing the polymer-free Amphilimus™ eluting stent to the Everolimus eluting stent in all-comer Diabetes Mellitus patients’ Prof Roxana Mehran (Mount Sinai Hospital, New York) outlines the:
• Challenges of all the novel drug eluting stents in diabetic patients
• Cre8™ EVO unique technologies compared to contemporary DES
• DIAB8 study design and its future influence on the management of diabetics undergoing PCI
